Homebiotech

biotech

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026

biotech

Meteor Biotech joins brain organoids consortium

Jim Cornall - June 25, 2026

biotech

Can food influence gene activity?

Jim Cornall - June 24, 2026

biotech

Orphan Drug Designation for potential best-in-class ADC for sarcoma

Jim Cornall - June 9, 2026

biotech

FDA Breakthrough Therapy Designation for spinal muscular atrophy treatment

Jim Cornall - June 9, 2026

biotech

Servier acquiring Edgewise Therapeutics’ muscular dystrophy business

Jim Cornall - June 9, 2026

biotech

Antibody fragment prevents haemorrhages associated with new Alzheimer’s treatments

Jim Cornall - June 8, 2026

biotech

Fast Track Designation for Lynch syndrome-associated cancers treatment

Jim Cornall - June 8, 2026

biotech

Positive data from linear IgA disease study

Jim Cornall - June 8, 2026

biotech

Base to Base biotech podcast 62: A new approach to strokes

Jim Cornall - June 5, 2026

biotech

Blood and biomarker testing service launches in Scotland for earlier Alzheimer’s diagnosis

Jim Cornall - June 4, 2026

1...345...85 Page 4 of 85

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026 0

Vedana Therapeutics, a biotechnology company developing next-generation therapies for migraine prevention, has emerged from stealth with $46m in Series A financing. The financing was co-led...

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

biotech Jim Cornall - June 25, 2026 0

Meteor Biotech joins brain organoids consortium

biotech Jim Cornall - June 25, 2026 0

Can food influence gene activity?

biotech Jim Cornall - June 24, 2026 0

Lab-engineered proteins: a promising treatment for liver disease

biotech Jim Cornall - June 24, 2026 0